{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:49:17Z","timestamp":1792046957811,"version":"4.4.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Kidney-derived c-kit<jats:sup>+<\/jats:sup> cells exhibit progenitor\/stem cell properties and can regenerate epithelial tubular cells following ischemia-reperfusion injury in rats. We therefore investigated whether c-kit<jats:sup>+<\/jats:sup> progenitor\/stem cells contribute to podocyte repair in a rat model of acute proteinuria induced by puromycin aminonucleoside (PAN), the experimental prototype of human minimal change disease and early stages of focal and segmental glomerulosclerosis. We found that c-kit<jats:sup>+<\/jats:sup> progenitor\/stem cells accelerated kidney recovery by improving foot process effacement (foot process width was lower in c-kit group <jats:italic>vs<\/jats:italic> saline treated animals, <jats:italic>P<\/jats:italic>\u2009=\u20090.03). In particular, these cells engrafted in small quantity into tubules, vessels, and glomeruli, where they occasionally differentiated into podocyte-like cells. This effect was related to an up regulation of \u03b1-Actinin-4 and mTORC2-Rictor pathway. Activation of autophagy by c-kit<jats:sup>+<\/jats:sup> progenitor\/stem cells also contributed to kidney regeneration and intracellular homeostasis (autophagosomes and autophagolysosomes number and LC3A\/B-I and LC3A\/B-II expression were higher in the c-kit group <jats:italic>vs<\/jats:italic> saline treated animals, <jats:italic>P<\/jats:italic>\u2009=\u20090.0031 and <jats:italic>P<\/jats:italic>\u2009=\u20090.0009, respectively). Taken together, our findings suggest that kidney-derived c-kit<jats:sup>+<\/jats:sup> progenitor\/stem cells exert reparative effects on glomerular disease processes through paracrine effects, to a lesser extent differentiation into podocyte-like cells and contribution to maintenance of podocyte cytoskeleton after injury. These findings have clinical implications for cell therapy of glomerular pathobiology.<\/jats:p>","DOI":"10.1038\/s41598-018-33082-x","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T09:10:31Z","timestamp":1538039431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Kidney-derived c-kit+ progenitor\/stem cells contribute to podocyte recovery in a model of acute proteinuria"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-2484","authenticated-orcid":false,"given":"Erika B.","family":"Rangel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samirah A.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemeire","family":"Kanashiro-Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell G.","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7751-5032","authenticated-orcid":false,"given":"Joshua M.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"33082_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00020.2002","volume":"83","author":"H Pavenstadt","year":"2003","unstructured":"Pavenstadt, H., Kriz, W. & Kretzler, M. Cell biology of the glomerular podocyte. Physiol Rev. 83, 253\u2013307 (2003).","journal-title":"Physiol Rev."},{"key":"33082_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature09669","volume":"470","author":"CQ Diep","year":"2011","unstructured":"Diep, C. Q. et al. Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature 470, 95\u2013100 (2011).","journal-title":"Nature"},{"key":"33082_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneph.2013.257","volume":"10","author":"L Biancone","year":"2014","unstructured":"Biancone, L. & Camussi, G. Stem cells in 2013: Potential use of stem or progenitor cells for kidney regeneration. Nat. Rev. Nephrol. 10, 67\u201368 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"33082_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ajpath.2010.10.024","volume":"178","author":"C Meyer-Schwesinger","year":"2011","unstructured":"Meyer-Schwesinger, C. et al. Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am. J. Pathol. 178, 494\u2013499 (2011).","journal-title":"Am. J. Pathol."},{"key":"33082_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1681\/ASN.2008070709","volume":"20","author":"E Ronconi","year":"2009","unstructured":"Ronconi, E. et al. Regeneration of glomerular podocytes by human renal progenitors. J. Am. Soc. Nephrol. 20, 322\u2013332 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1681\/ASN.2008070795","volume":"20","author":"D Appel","year":"2009","unstructured":"Appel, D. et al. Recruitment of podocytes from glomerular parietal epithelial cells. J. Am. Soc. Nephrol. 20, 333\u2013343 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1681\/ASN.2013050481","volume":"25","author":"K Berger","year":"2014","unstructured":"Berger, K. et al. The regenerative potential of parietal epithelial cells in adult mice. J. Am. Soc. Nephrol. 25, 693\u2013705 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1681\/ASN.2012050445","volume":"24","author":"W Pichaiwong","year":"2013","unstructured":"Pichaiwong, W. et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J. Am. Soc. Nephrol. 24, 1088\u20131102 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stemcr.2015.07.003","volume":"5","author":"L Lasagni","year":"2015","unstructured":"Lasagni, L. et al. Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced. Stem Cell Reports. 5, 248\u2013263 (2015).","journal-title":"Stem Cell Reports."},{"key":"33082_CR10","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2009020132","volume":"20","author":"B Smeets","year":"2009","unstructured":"Smeets, B. et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J. Am. Soc. Nephrol. 20, 2593\u20132603 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR11","doi-asserted-by":"publisher","first-page":"F1370","DOI":"10.1152\/ajprenal.00057.2012","volume":"303","author":"C Zoja","year":"2012","unstructured":"Zoja, C. et al. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. Am. J. Physiol Renal Physiol 303, F1370\u2013F1381 (2012).","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"33082_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.transproceed.2009.01.072","volume":"41","author":"RC Cavaglieri","year":"2009","unstructured":"Cavaglieri, R. C., Martini, D., Sogayar, M. C. & Noronha, I. L. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant. Proc. 41, 947\u2013951 (2009).","journal-title":"Transplant. Proc."},{"key":"33082_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3727\/096368908787236567","volume":"17","author":"A Magnasco","year":"2008","unstructured":"Magnasco, A. et al. Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transplant. 17, 1157\u20131167 (2008).","journal-title":"Cell Transplant."},{"key":"33082_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.ki.5001521","volume":"70","author":"V Ninichuk","year":"2006","unstructured":"Ninichuk, V. et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 70, 121\u2013129 (2006).","journal-title":"Kidney Int."},{"key":"33082_CR15","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1681\/ASN.2005080815","volume":"17","author":"U Kunter","year":"2006","unstructured":"Kunter, U. et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J. Am. Soc. Nephrol. 17, 2202\u20132212 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1681\/ASN.2007010044","volume":"18","author":"U Kunter","year":"2007","unstructured":"Kunter, U. et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 18, 1754\u20131764 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1681\/ASN.2009111156","volume":"21","author":"D Thirabanjasak","year":"2010","unstructured":"Thirabanjasak, D., Tantiwongse, K. & Thorner, P. S. Angiomyeloproliferative lesions following autologous stem cell therapy. J. Am. Soc. Nephrol. 21, 1218\u20131222 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2011030243","volume":"23","author":"S Sedrakyan","year":"2012","unstructured":"Sedrakyan, S. et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J. Am. Soc. Nephrol. 23, 661\u2013673 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR19","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1634\/stemcells.2006-0201","volume":"24","author":"EI Prodromidi","year":"2006","unstructured":"Prodromidi, E. I. et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24, 2448\u20132455 (2006).","journal-title":"Stem Cells"},{"key":"33082_CR20","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1073\/pnas.0601436103","volume":"103","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto, H. et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc. Natl. Acad. Sci. USA 103, 7321\u20137326 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33082_CR21","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/stem.1412","volume":"31","author":"EB Rangel","year":"2013","unstructured":"Rangel, E. B. et al. C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential. Stem Cells 31, 1644\u20131656 (2013).","journal-title":"Stem Cells"},{"key":"33082_CR22","doi-asserted-by":"publisher","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","volume":"296","author":"JW Pippin","year":"2009","unstructured":"Pippin, J. W. et al. Inducible rodent models of acquired podocyte diseases. Am. J. Physiol Renal Physiol 296, F213\u2013F229 (2009).","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"33082_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI39492","volume":"120","author":"B Hartleben","year":"2010","unstructured":"Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest 120, 1084\u20131096 (2010).","journal-title":"J. Clin. Invest"},{"key":"33082_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1096\/fj.02-0580fje","volume":"17","author":"K Asanuma","year":"2003","unstructured":"Asanuma, K. et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J. 17, 1165\u20131167 (2003).","journal-title":"FASEB J."},{"key":"33082_CR25","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/jcp.24351","volume":"228","author":"A Alayev","year":"2013","unstructured":"Alayev, A. & Holz, M. K. mTOR signaling for biological control and cancer. J. Cell Physiol 228, 1658\u20131664 (2013).","journal-title":"J. Cell Physiol"},{"key":"33082_CR26","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI44774","volume":"121","author":"M Godel","year":"2011","unstructured":"Godel, M. et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest 121, 2197\u20132209 (2011).","journal-title":"J. Clin. Invest"},{"key":"33082_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1172\/JCI44771","volume":"121","author":"K Inoki","year":"2011","unstructured":"Inoki, K. et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest 121, 2181\u20132196 (2011).","journal-title":"J. Clin. Invest"},{"key":"33082_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/ndt\/gfr240","volume":"27","author":"Y Zuo","year":"2012","unstructured":"Zuo, Y. et al. Protective effects of PPARgamma agonist in acute nephrotic syndrome. Nephrol. Dial. Transplant. 27, 174\u2013181 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"33082_CR29","first-page":"F82","volume":"268","author":"ME Pagtalunan","year":"1995","unstructured":"Pagtalunan, M. E., Rasch, R., Rennke, H. G. & Meyer, T. W. Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am. J. Physiol 268, F82\u2013F88 (1995).","journal-title":"Am. J. Physiol"},{"key":"33082_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069\u20131075 (2008).","journal-title":"Nature"},{"key":"33082_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313\u2013326 (2010).","journal-title":"Cell"},{"issue":"12","key":"33082_CR32","doi-asserted-by":"publisher","first-page":"a008771","DOI":"10.1101\/cshperspect.a008771","volume":"4","author":"C.-M. Hung","year":"2012","unstructured":"Hung, C. M., Garcia-Haro, L., Sparks, C. A. & Guertin, D. A. mTOR-dependent cell survival mechanisms. Cold Spring Harb. Perspect. Biol. 4 (2012).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"33082_CR33","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1681\/ASN.2006101145","volume":"18","author":"JJ Kim","year":"2007","unstructured":"Kim, J. J. et al. Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J. Am. Soc. Nephrol. 18, 2303\u20132310 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR34","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1172\/JCI65289","volume":"122","author":"K Soda","year":"2012","unstructured":"Soda, K. et al. Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J. Clin. Invest 122, 4401\u20134411 (2012).","journal-title":"J. Clin. Invest"},{"key":"33082_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","volume":"17","author":"C Faul","year":"2007","unstructured":"Faul, C., Asanuma, K., Yanagida-Asanuma, E., Kim, K. & Mundel, P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 17, 428\u2013437 (2007).","journal-title":"Trends Cell Biol."},{"key":"33082_CR36","first-page":"541","volume":"44","author":"T Seefeldt","year":"1981","unstructured":"Seefeldt, T. et al. Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis. Lab Invest 44, 541\u2013546 (1981).","journal-title":"Lab Invest"},{"key":"33082_CR37","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/j.1523-1755.2004.00964.x","volume":"66","author":"JG van den Berg","year":"2004","unstructured":"van den Berg, J. G., van den Bergh Weerman, M. A., Assmann, K. J., Weening, J. J. & Florquin, S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int. 66, 1901\u20131906 (2004).","journal-title":"Kidney Int."},{"key":"33082_CR38","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/ndt\/15.10.1547","volume":"15","author":"EK Lowenborg","year":"2000","unstructured":"Lowenborg, E. K., Jaremko, G. & Berg, U. B. Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats. Nephrol. Dial. Transplant. 15, 1547\u20131555 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"33082_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/ki.1988.29","volume":"33","author":"J Grond","year":"1988","unstructured":"Grond, J., Muller, E. W., van, G. H., Weening, J. J. & Elema, J. D. Differences in puromycin aminonucleoside nephrosis in two rat strains. Kidney Int. 33, 524\u2013529 (1988).","journal-title":"Kidney Int."},{"key":"33082_CR40","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1681\/ASN.2014090859","volume":"26","author":"HW Lee","year":"2015","unstructured":"Lee, H. W. et al. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J. Am. Soc. Nephrol. 26, 2741\u20132752 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jgr.2014.05.004","volume":"38","author":"TS Ha","year":"2014","unstructured":"Ha, T. S., Choi, J. Y., Park, H. Y., Nam, J. A. & Seong, S. B. Ginseng total saponin modulates the changes of alpha-actinin-4 in podocytes induced by diabetic conditions. J. Ginseng. Res. 38, 233\u2013238 (2014).","journal-title":"J. Ginseng. Res."},{"key":"33082_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.transproceed.2006.12.019","volume":"39","author":"S Schrepfer","year":"2007","unstructured":"Schrepfer, S. et al. Stem cell transplantation: the lung barrier. Transplant. Proc. 39, 573\u2013576 (2007).","journal-title":"Transplant. Proc."},{"key":"33082_CR43","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","volume":"12","author":"F Casiraghi","year":"2012","unstructured":"Casiraghi, F. et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am. J. Transplant. 12, 2373\u20132383 (2012).","journal-title":"Am. J. Transplant."},{"key":"33082_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000052600","volume":"9","author":"L Fernandez","year":"2001","unstructured":"Fernandez, L., Romero, M., Soto, H. & Mosquera, J. Increased apoptosis in acute puromycin aminonucleoside nephrosis. Exp. Nephrol. 9, 99\u2013108 (2001).","journal-title":"Exp. Nephrol."},{"key":"33082_CR45","doi-asserted-by":"publisher","first-page":"F898","DOI":"10.1152\/ajprenal.00124.2010","volume":"299","author":"A Granqvist","year":"2010","unstructured":"Granqvist, A., Nilsson, U. A., Ebefors, K., Haraldsson, B. & Nystrom, J. Impaired glomerular and tubular antioxidative defense mechanisms in nephrotic syndrome. Am. J. Physiol Renal Physiol 299, F898\u2013F904 (2010).","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"33082_CR46","doi-asserted-by":"publisher","first-page":"e78144","DOI":"10.1371\/journal.pone.0078144","volume":"8","author":"J Yi","year":"2013","unstructured":"Yi, J. et al. Analysis of LGR4 receptor distribution in human and mouse tissues. PLoS. One. 8, e78144 (2013).","journal-title":"PLoS. One."},{"key":"33082_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ydbio.2014.03.009","volume":"390","author":"B Kinzel","year":"2014","unstructured":"Kinzel, B. et al. Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. Dev. Biol. 390, 181\u2013190 (2014).","journal-title":"Dev. Biol."},{"key":"33082_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer, U. M. et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18, 683\u2013692 (2009).","journal-title":"Stem Cells Dev."},{"key":"33082_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/nep.12018","volume":"18","author":"Y Wang","year":"2013","unstructured":"Wang, Y., He, J., Pei, X. & Zhao, W. Systematic review and meta-analysis of mesenchymal stem\/stromal cells therapy for impaired renal function in small animal models. Nephrology. (Carlton.) 18, 201\u2013208 (2013).","journal-title":"Nephrology. (Carlton.)"},{"key":"33082_CR50","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico, N. et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 6, 412\u2013422 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"33082_CR51","first-page":"F150","volume":"273","author":"WE Smoyer","year":"1997","unstructured":"Smoyer, W. E., Mundel, P., Gupta, A. & Welsh, M. J. Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome. Am. J. Physiol 273, F150\u2013F157 (1997).","journal-title":"Am. J. Physiol"},{"key":"33082_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/01.LAB.0000017168.26718.16","volume":"82","author":"P Luimula","year":"2002","unstructured":"Luimula, P., Sandstrom, N., Novikov, D. & Holthofer, H. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 82, 713\u2013718 (2002).","journal-title":"Lab Invest"},{"key":"33082_CR53","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2169\/internalmedicine.47.0352","volume":"47","author":"M Kimura","year":"2008","unstructured":"Kimura, M. et al. Expression of alpha-actinin-4 in human diabetic nephropathy. Intern. Med. 47, 1099\u20131106 (2008).","journal-title":"Intern. Med."},{"key":"33082_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1681\/ASN.2007030276","volume":"19","author":"AS Awad","year":"2008","unstructured":"Awad, A. S. et al. Activation of adenosine 2A receptors preserves structure and function of podocytes. J. Am. Soc. Nephrol. 19, 59\u201368 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1440-1797.2012.01645.x","volume":"17","author":"H Liu","year":"2012","unstructured":"Liu, H. et al. alpha-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury. Nephrology. (Carlton.) 17, 669\u2013675 (2012).","journal-title":"Nephrology. (Carlton.)"},{"key":"33082_CR56","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1074\/jbc.M605024200","volume":"282","author":"SV Dandapani","year":"2007","unstructured":"Dandapani, S. V. et al. Alpha-actinin-4 is required for normal podocyte adhesion. J. Biol. Chem. 282, 467\u2013477 (2007).","journal-title":"J. Biol. Chem."},{"key":"33082_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/73456","volume":"24","author":"JM Kaplan","year":"2000","unstructured":"Kaplan, J. M. et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24, 251\u2013256 (2000).","journal-title":"Nat. Genet."},{"key":"33082_CR58","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1172\/JCI17988","volume":"111","author":"CH Kos","year":"2003","unstructured":"Kos, C. H. et al. Mice deficient in alpha-actinin-4 have severe glomerular disease. J. Clin. Invest 111, 1683\u20131690 (2003).","journal-title":"J. Clin. Invest"},{"key":"33082_CR59","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/ki.1993.380","volume":"44","author":"H Trachtman","year":"1993","unstructured":"Trachtman, H., Futterweit, S., Schwob, N., Maesaka, J. & Valderrama, E. Recombinant human growth hormone exacerbates chronic puromycin aminonucleoside nephropathy in rats. Kidney Int. 44, 1281\u20131288 (1993).","journal-title":"Kidney Int."},{"key":"33082_CR60","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1681\/ASN.2008070782","volume":"20","author":"JS Nielsen","year":"2009","unstructured":"Nielsen, J. S. & McNagny, K. M. The role of podocalyxin in health and disease. J. Am. Soc. Nephrol. 20, 1669\u20131676 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR61","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1083\/jcb.102.2.484","volume":"102","author":"R Horvat","year":"1986","unstructured":"Horvat, R., Hovorka, A., Dekan, G., Poczewski, H. & Kerjaschki, D. Endothelial cell membranes contain podocalyxin\u2013the major sialoprotein of visceral glomerular epithelial cells. J. Cell Biol. 102, 484\u2013491 (1986).","journal-title":"J. Cell Biol."},{"key":"33082_CR62","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1440-1797.2010.01285.x","volume":"15","author":"H Fujinaka","year":"2010","unstructured":"Fujinaka, H. et al. Expression and localization of insulin-like growth factor binding proteins in normal and proteinuric kidney glomeruli. Nephrology. (Carlton.) 15, 700\u2013709 (2010).","journal-title":"Nephrology. (Carlton.)"},{"key":"33082_CR63","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1523-1755.2005.00208.x","volume":"67","author":"DJ Bridgewater","year":"2005","unstructured":"Bridgewater, D. J., Ho, J., Sauro, V. & Matsell, D. G. Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. Kidney Int. 67, 1308\u20131314 (2005).","journal-title":"Kidney Int."},{"key":"33082_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1203\/PDR.0b013e31821bdf1c","volume":"70","author":"J Ma","year":"2011","unstructured":"Ma, J. et al. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside. Pediatr. Res. 70, 83\u201389 (2011).","journal-title":"Pediatr. Res."},{"key":"33082_CR65","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1440-1797.2010.01392.x","volume":"16","author":"T Kato","year":"2011","unstructured":"Kato, T., Mizuno, S. & Nakamura, T. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice. Nephrology. (Carlton.) 16, 310\u2013318 (2011).","journal-title":"Nephrology. (Carlton.)"},{"key":"33082_CR66","doi-asserted-by":"publisher","first-page":"F784","DOI":"10.1152\/ajprenal.00210.2011","volume":"301","author":"X Bu","year":"2011","unstructured":"Bu, X. et al. Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes. Am. J. Physiol Renal Physiol 301, F784\u2013F792 (2011).","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"33082_CR67","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00125-012-2535-z","volume":"55","author":"M Flaquer","year":"2012","unstructured":"Flaquer, M. et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db\/db mice as a model of diabetes. Diabetologia 55, 2059\u20132068 (2012).","journal-title":"Diabetologia"},{"key":"33082_CR68","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1073\/pnas.1220185110","volume":"110","author":"SA Gomes","year":"2013","unstructured":"Gomes, S. A. et al. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc. Natl. Acad. Sci. USA 110, 2834\u20132839 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33082_CR69","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1681\/ASN.2010030295","volume":"21","author":"K Sison","year":"2010","unstructured":"Sison, K. et al. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J. Am. Soc. Nephrol. 21, 1691\u20131701 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR70","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border, W. A. & Noble, N. A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331, 1286\u20131292 (1994).","journal-title":"N. Engl. J. Med."},{"key":"33082_CR71","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","volume":"13","author":"EP Bottinger","year":"2002","unstructured":"Bottinger, E. P. & Bitzer, M. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 13, 2600\u20132610 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR72","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI200112367","volume":"108","author":"M Schiffer","year":"2001","unstructured":"Schiffer, M. et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J. Clin. Invest 108, 807\u2013816 (2001).","journal-title":"J. Clin. Invest"},{"key":"33082_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jcb.24303","volume":"114","author":"Y Lee","year":"2013","unstructured":"Lee, Y. et al. Increased SCF\/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J. Cell Biochem. 114, 79\u201388 (2013).","journal-title":"J. Cell Biochem."},{"key":"33082_CR74","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1681\/ASN.2011070690","volume":"23","author":"DP Cina","year":"2012","unstructured":"Cina, D. P. et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J. Am. Soc. Nephrol. 23, 412\u2013420 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR75","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2012111080","volume":"24","author":"K Yamahara","year":"2013","unstructured":"Yamahara, K. et al. Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J. Am. Soc. Nephrol. 24, 1769\u20131781 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33082_CR76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2967\/jnumed.111.089623","volume":"52","author":"R Watanabe","year":"2011","unstructured":"Watanabe, R., Wei, L. & Huang, J. mTOR signaling, function, novel inhibitors, and therapeutic targets. J. Nucl. Med. 52, 497\u2013500 (2011).","journal-title":"J. Nucl. Med."},{"key":"33082_CR77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","volume":"40","author":"S Sengupta","year":"2010","unstructured":"Sengupta, S., Peterson, T. R. & Sabatini, D. M. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310\u2013322 (2010).","journal-title":"Mol. Cell"},{"key":"33082_CR78","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","volume":"68","author":"RF Ransom","year":"2005","unstructured":"Ransom, R. F., Lam, N. G., Hallett, M. A., Atkinson, S. J. & Smoyer, W. E. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int. 68, 2473\u20132483 (2005).","journal-title":"Kidney Int."},{"key":"33082_CR79","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.ki.5002311","volume":"72","author":"N Eto","year":"2007","unstructured":"Eto, N. et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int. 72, 455\u2013463 (2007).","journal-title":"Kidney Int."},{"key":"33082_CR80","doi-asserted-by":"publisher","first-page":"e55980","DOI":"10.1371\/journal.pone.0055980","volume":"8","author":"S Jeruschke","year":"2013","unstructured":"Jeruschke, S. et al. Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling. PLoS. One. 8, e55980 (2013).","journal-title":"PLoS. One."},{"key":"33082_CR81","doi-asserted-by":"publisher","first-page":"e63799","DOI":"10.1371\/journal.pone.0063799","volume":"8","author":"L Wu","year":"2013","unstructured":"Wu, L. et al. Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury. PLoS. One. 8, e63799 (2013).","journal-title":"PLoS. One."},{"key":"33082_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","volume":"23","author":"M Cornu","year":"2013","unstructured":"Cornu, M., Albert, V. & Hall, M. N. mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 23, 53\u201362 (2013).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"33082_CR83","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/emboj.2008.119","volume":"27","author":"T Ikenoue","year":"2008","unstructured":"Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. & Guan, K. L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919\u20131931 (2008).","journal-title":"EMBO J."},{"key":"33082_CR84","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122\u20131128 (2004).","journal-title":"Nat. Cell Biol."},{"key":"33082_CR85","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302 (2004).","journal-title":"Curr. Biol."},{"key":"33082_CR86","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm.3313","volume":"19","author":"G Canaud","year":"2013","unstructured":"Canaud, G. et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat. Med. 19, 1288\u20131296 (2013).","journal-title":"Nat. Med."},{"key":"33082_CR87","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.devcel.2006.08.013","volume":"11","author":"C Shiota","year":"2006","unstructured":"Shiota, C., Woo, J. T., Lindner, J., Shelton, K. D. & Magnuson, M. A. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 11, 583\u2013589 (2006).","journal-title":"Dev. Cell"},{"key":"33082_CR88","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","volume":"8","author":"CF Bentzinger","year":"2008","unstructured":"Bentzinger, C. F. et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8, 411\u2013424 (2008).","journal-title":"Cell Metab"},{"key":"33082_CR89","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.1073\/pnas.0811321106","volume":"106","author":"N Cybulski","year":"2009","unstructured":"Cybulski, N., Polak, P., Auwerx, J., Ruegg, M. A. & Hall, M. N. mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc. Natl. Acad. Sci. USA 106, 9902\u20139907 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33082_CR90","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1083\/jcb.201205030","volume":"201","author":"V Thomanetz","year":"2013","unstructured":"Thomanetz, V. et al. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J. Cell Biol. 201, 293\u2013308 (2013).","journal-title":"J. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33082-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:12:51Z","timestamp":1671617571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33082-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33082"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33082-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14723"}}